Found 6 matching trials
Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal) PHASE1 The purpose of this study is to determine the pharmacokinetics (PK) and saf...
Show More Location
Colorado Blood Cancer Institute
Learn More & Join Trial
Selinexor and Backbone Treatments of Multiple Myeloma Patients PHASE1 This study will independently assess the efficacy and safety of 11 combinat...
Show More Location
Banner MD Anderson Cancer Center
Learn More & Join Trial
Comparison of Pom and Dex in Subjects With RRMM Previously Treated With Len and a PI Dara/Pom/Dex vs Pom/Dex PHASE3 The purpose of this study is to evaluate the effects of the addition of dar...
Show More Learn More & Join Trial
Pom-dex Versus Pom-Cyclo-dex in MM Patients With Biochemical or Clinical Relapse, During Lena Maintenance Treatment PHASE3 The combination lenalidomide plus low-dose dexamethasone (Rd) is an active ...
Show More Location
Fondazione EMN Italy Onlus
Learn More & Join Trial
Elotuzumab, Pomalidomide, & Dexamethasone (Elo-Pom-Dex) With Second Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma PHASE2 Based on the need to improve outcomes post second autologous stem cell tran...
Show More Status
Active Not Recruiting
Location
Colorado Blood Cancer Institute (Sarah Cannon)
Learn More & Join Trial
A Study to Determine Dose and Regimen of Durvalumab as Monotherapy or in Combination With Pomalidomide With or Without Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma PHASE1 This is a multicenter, open-label, Phase 1b study to determine the recommen...
Show More Location
Local Institution - 102
Learn More & Join Trial